Evaluation of the Inhibition Potency of Nirmatrelvir against Main Protease Mutants of SARS-CoV-2 Variants. Jiang H, Zhou Y, Zou X, Hu X, et al. Biochemistry 2023;62:2055-2064.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Jiang H, Zhou Y, Zou X, Hu X, et al. Evaluation of the Inhibition Potency of Nirmatrelvir against Main Protease Mutants of SARS-CoV-2 Variants. Biochemistry 2023;62:2055-2064.
PMID: 37222536